Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancer

Clinical trial NCT01658176 · WITHDRAWN

Trial details

NCT number: NCT01658176
Sponsor: Pfizer
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2013-01-01
Primary completion: 2015-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.